Canada markets close in 2 hours 24 minutes

Xeris Biopharma Holdings, Inc. (XERS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.8475+0.0975 (+5.56%)
As of 01:36PM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts6665
Avg. Estimate-0.12-0.1-0.38-0.22
Low Estimate-0.14-0.12-0.47-0.35
High Estimate-0.11-0.09-0.29-0.13
Year Ago EPS-0.12-0.14-0.45-0.38
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts6666
Avg. Estimate41.81M45.1M184.43M219.33M
Low Estimate37.97M43.88M176.7M195.2M
High Estimate44M47.6M194.2M230.4M
Year Ago Sales33.2M38.01M163.91M184.43M
Sales Growth (year/est)25.90%18.70%12.50%18.90%
Earnings History2023-03-302023-06-292023-09-292023-12-30
EPS Est.-0.17-0.13-0.12-0.1
EPS Actual-0.12-0.14-0.09-0.1
Difference0.05-0.010.030
Surprise %29.40%-7.70%25.00%0.00%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.12-0.1-0.38-0.22
7 Days Ago-0.12-0.1-0.38-0.22
30 Days Ago-0.12-0.1-0.38-0.22
60 Days Ago-0.09-0.07-0.27-0.05
90 Days Ago-0.09-0.07-0.29-0.06
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesXERSIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.28.60%N/AN/AN/A
Current Year15.60%N/AN/AN/A
Next Year42.10%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A